0001127602-22-014973.txt : 20220518 0001127602-22-014973.hdr.sgml : 20220518 20220518164510 ACCESSION NUMBER: 0001127602-22-014973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keresty Georgia CENTRAL INDEX KEY: 0001773532 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34630 FILM NUMBER: 22939761 MAIL ADDRESS: STREET 1: C/O ASPEN TECHNOLOGY, INC. STREET 2: 20 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASPENTECH Corp CENTRAL INDEX KEY: 0000929940 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] IRS NUMBER: 042739697 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 20 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-221-4302 MAIL ADDRESS: STREET 1: 20 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASPEN TECHNOLOGY INC /DE/ DATE OF NAME CHANGE: 19980527 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-05-16 1 0000929940 ASPENTECH Corp AZPN 0001773532 Keresty Georgia C/O ASPEN TECHNOLOGY, INC. 20 CROSBY DRIVE BEDFORD MA 01730 1 Common Stock 2022-05-16 4 D 0 3465 D 0 D Director Stock Option (Right to Buy) 109.97 2022-05-16 4 D 0 1684 D 2029-04-16 Common Stock 1684 0 D Director Stock Option (Right to Buy) 133.20 2022-05-16 4 D 0 1444 D 2029-09-02 Common Stock 1444 0 D Director Stock Option (Right to Buy) 130.51 2022-05-16 4 D 0 303 D 2030-12-27 Common Stock 303 0 D Director Stock Option (Right to Buy) 129.50 2022-05-16 4 D 0 1531 D 2031-08-31 Common Stock 1531 0 D On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech. One third of the option granted at the exercise price of $109.97 will vest on the first anniversary of the grant date and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested. Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. The option granted at the exercise price of $133.20 was fully vested on the date of grant. The option granted at the exercise price of $130.51 was fully vested on the date of grant. The option granted at the exercise price of $129.50 was fully vested on the date of grant. /s/ F.G. Hammond, attorney-in-fact for Ms. Keresty 2022-05-18